Recombinant Human IL-13

• Description:

  Recombinant Human IL-13_x000D_ Catalog number: B2018470_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 µg_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: Interleukin-13, IL-13_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Suzuki A, Leland P, Joshi BH, Puri RK. Targeting of IL-4 and IL-13 receptors for cancer therapy Cytokine. 2015 Sep;75(1):79-88._x000D_ 2: Keam SJ. Lebrikizumab: First Approval Drugs. 2024 Mar;84(3):347-353._x000D_ 3: LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM, Keegan AD, Garcia KC. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system Cell. 2008 Jan 25;132(2):259-72._x000D_ 4: Khalil SM, Bernstein I, Kulaga H, Gour N, Rowan N, Lajoie S, Lane AP. Interleukin 13 (IL-13) alters hypoxia-associated genes and upregulates CD73 Int Forum Allergy Rhinol. 2020 Sep;10(9):1096-1102._x000D_ 5: Rogers KJ, Brunton B, Mallinger L, Bohan D, Sevcik KM, Chen J, Ruggio N, Maury W. IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection PLoS Negl Trop Dis. 2019 Dec 11;13(12):e0007819._x000D_ 6: Cho WK, Lee CM, Kang MJ, Huang Y, Giordano FJ, Lee PJ, Trow TK, Homer RJ, Sessa WC, Elias JA, Lee CG. IL-13 receptor α2-arginase 2 pathway mediates IL-13-induced pulmonary hypertension Am J Physiol Lung Cell Mol Physiol. 2013 Jan 15;304(2):L112-24._x000D_ 7: Shimamura T, Husain SR, Puri RK. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy Neurosurg Focus. 2006 Apr 15;20(4):E11._x000D_ 8: Fransson J, Teplyakov A, Raghunathan G, Chi E, Cordier W, Dinh T, Feng Y, Giles-Komar J, Gilliland G, Lollo B, Malia TJ, Nishioka W, Obmolova G, Zhao S, Zhao Y, Swanson RV, Almagro JC. Human framework adaptation of a mouse anti-human IL-13 antibody J Mol Biol. 2010 Apr 30;398(2):214-31._x000D_ 9: Lind M, Deleuran B, Yssel H, Fink-Eriksen E, Thestrup-Pedersen K. IL-4 and IL-13, but not IL-10, are chemotactic factors for human osteoblasts Cytokine. 1995 Jan;7(1):78-82._x000D_ 10: Knackmuss S, Krause S, Engel K, Reusch U, Virchow JC, Mueller T, Kraich M, Little M, Luttmann W, Friedrich K. Specific inhibition of interleukin-13 activity by a recombinant human single-chain immunoglobulin domain directed against the IL-13 receptor alpha1 chain Biol Chem. 2007 Mar;388(3):325-30. _x000D_ _x000D_ Products Related to Recombinant Human IL-13 can be found at Proteins

• Short Description:

  Catalog Number: B2018470 (1 µg)_x000D_ Recombinant Human IL-13 is a form of the human protein Interleukin-13 (IL-13) that is produced through genetic engineering techniques. IL-13 is a cytokine that plays a role in regulating immune responses and inflammation in the body. Recombinant Human IL-13 is often used in research to study its effects on cells and tissues. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5

• CAS Number:

  9000-83-3